Both in Biotechnology
Palisade Bio vs Inhibikase Therapeutics
Over the past year PALI returned −44.0% and IKT returned −3.8%; their daily moves had a correlation of 0.15.
PALI −44.0% IKT −3.8%Growth of $1, one year, split-adjusted
| Metric | PALI | IKT |
|---|---|---|
| Price | $1.12 | $1.54 |
| Market cap | $195.2M | $214.9M |
| Today | −3.45% | −0.65% |
| 1 month | −22.2% | −23.0% |
| 6 months | −47.4% | −20.6% |
| Year to date | −52.3% | −24.9% |
| 1 year | −42.3% | +5.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −2114.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 390.4× | — |
| Net cash | $125.2M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 50.5% |
| Short % of float | 18.3% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).